Hawkins, Inc. $HWKN Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC lessened its holdings in Hawkins, Inc. (NASDAQ:HWKNFree Report) by 18.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,187 shares of the specialty chemicals company’s stock after selling 5,020 shares during the period. Rice Hall James & Associates LLC’s holdings in Hawkins were worth $4,054,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of HWKN. Montanaro Asset Management Ltd boosted its holdings in Hawkins by 294.0% during the 2nd quarter. Montanaro Asset Management Ltd now owns 59,100 shares of the specialty chemicals company’s stock valued at $8,398,000 after acquiring an additional 44,100 shares during the period. Congress Asset Management Co. purchased a new stake in Hawkins during the second quarter worth about $16,956,000. Raymond James Financial Inc. lifted its position in shares of Hawkins by 2.8% during the first quarter. Raymond James Financial Inc. now owns 109,697 shares of the specialty chemicals company’s stock worth $11,619,000 after purchasing an additional 3,010 shares in the last quarter. Neuberger Berman Group LLC acquired a new stake in shares of Hawkins during the second quarter worth about $4,594,000. Finally, Sequoia Financial Advisors LLC purchased a new position in shares of Hawkins in the second quarter valued at approximately $332,000. 69.71% of the stock is currently owned by hedge funds and other institutional investors.

Hawkins Stock Up 0.1%

Shares of Hawkins stock opened at $146.82 on Friday. Hawkins, Inc. has a 52-week low of $98.30 and a 52-week high of $186.15. The company has a 50 day moving average of $139.96 and a 200 day moving average of $155.39. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $3.07 billion, a P/E ratio of 36.89, a P/E/G ratio of 2.27 and a beta of 0.86.

Hawkins (NASDAQ:HWKNGet Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The specialty chemicals company reported $1.08 EPS for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). Hawkins had a net margin of 7.95% and a return on equity of 17.42%. The firm had revenue of $280.43 million during the quarter, compared to analysts’ expectations of $284.42 million. As a group, research analysts forecast that Hawkins, Inc. will post 4 EPS for the current fiscal year.

Hawkins Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Friday, November 14th were issued a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Friday, November 14th. Hawkins’s dividend payout ratio is 19.10%.

Insiders Place Their Bets

In other Hawkins news, VP Drew M. Grahek purchased 1,587 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was bought at an average cost of $126.34 per share, with a total value of $200,501.58. Following the acquisition, the vice president directly owned 39,640 shares of the company’s stock, valued at approximately $5,008,117.60. This represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

HWKN has been the topic of several recent research reports. Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 4th. Weiss Ratings restated a “buy (b-)” rating on shares of Hawkins in a research note on Monday, December 22nd. Finally, BWS Financial reiterated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research note on Monday, November 3rd. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $162.50.

Get Our Latest Stock Report on Hawkins

About Hawkins

(Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

Read More

Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKNFree Report).

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.